Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 63 citing articles:

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
Xiaojun Feng, Antoni Sureda, Samineh Jafari, et al.
Theranostics (2019) Vol. 9, Iss. 7, pp. 1923-1951
Open Access | Times Cited: 326
Berberine pharmacology and the gut microbiota: A hidden therapeutic link
Solomon Habtemariam
Pharmacological Research (2020) Vol. 155, pp. 104722-104722
Closed Access | Times Cited: 242
Berberine, a Herbal Metabolite in the Metabolic Syndrome: The Risk Factors, Course, and Consequences of the Disease
Anna Och, Marek Och, Renata Nowak, et al.
Molecules (2022) Vol. 27, Iss. 4, pp. 1351-1351
Open Access | Times Cited: 50
Mitochondrial function in intestinal epithelium homeostasis and modulation in diet-induced obesity
Thomas Guerbette, Gaëlle Boudry, Annaïg Lan
Molecular Metabolism (2022) Vol. 63, pp. 101546-101546
Open Access | Times Cited: 48
Single-cell atlas reveals multi-faced responses of losartan on tubular mitochondria in diabetic kidney disease
Zhen Zhu, Guangxin Luan, Song Wu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Berberine in the treatment of metabolism-related chronic diseases: A drug cloud (dCloud) effect to target multifactorial disorders
Weijia Kong, Claudio Vernieri, Marco Foiani, et al.
Pharmacology & Therapeutics (2020) Vol. 209, pp. 107496-107496
Closed Access | Times Cited: 63
Mechanism of insulin resistance in obesity: a role of ATP
Jianping Ye
Frontiers of Medicine (2021) Vol. 15, Iss. 3, pp. 372-382
Open Access | Times Cited: 50
Dietary Supplements and Natural Products: An Update on Their Clinical Effectiveness and Molecular Mechanisms of Action During Accelerated Biological Aging
Ye Chen, Sherif Hamidu, Xintong Yang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 37
Research progress on the pharmacological effects of berberine targeting mitochondria
Xinyi Fang, Haoran Wu, Jiahua Wei, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 32
Role of Fenugreek, Cinnamon, Curcuma longa, Berberine and Momordica charantia in Type 2 Diabetes Mellitus Treatment: A Review
Marisol Cortez-Navarrete, Karina G. Pérez-Rubio, Miriam de J. Escobedo-Gutiérrez
Pharmaceuticals (2023) Vol. 16, Iss. 4, pp. 515-515
Open Access | Times Cited: 18
Saturated fatty acids differently affect mitochondrial function and the intestinal epithelial barrier depending on their chain length in the in vitro model of IPEC-J2 enterocytes
Thomas Guerbette, Vincent Rioux, Mégane Bostoën, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 7
Regulation of microbiota–GLP1 axis by sennoside A in diet-induced obese mice
Jiamei Le, Xiaoying Zhang, Weiping Jia, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 9, Iss. 4, pp. 758-768
Open Access | Times Cited: 50
Rhizoma coptidis as a Potential Treatment Agent for Type 2 Diabetes Mellitus and the Underlying Mechanisms: A Review
Qian Ran, Jin Wang, Lin Wang, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 43
Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1/PINK1 signaling in tubular cells
Zhen Zhu, Guangxin Luan, Shiqiao Peng, et al.
Phytomedicine (2023) Vol. 119, pp. 154975-154975
Closed Access | Times Cited: 14
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review
Noriko Shinjyo, James R.C. Parkinson, Jimmy D. Bell, et al.
Journal of Integrative Medicine (2020) Vol. 18, Iss. 2, pp. 125-151
Open Access | Times Cited: 34
Reactive Oxygen Species/Reactive Nitrogen Species as Messengers in the Gut: Impact on Physiology and Metabolic Disorders
Anne Abot, Steven G. Fried, Patrice D. Cani, et al.
Antioxidants and Redox Signaling (2021) Vol. 37, Iss. 4-6, pp. 394-415
Closed Access | Times Cited: 31
Berberine Metabolites Stimulate GLP-1 Secretion by Alleviating Oxidative Stress and Mitochondrial Dysfunction
Weili Yang, Chenyang Zhang, Wen-Yi Ji, et al.
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 01, pp. 253-274
Closed Access | Times Cited: 4
Bioenergetic adaptations of small intestinal epithelial cells reduce cell differentiation enhancing intestinal permeability in obese mice
Thomas Guerbette, Vincent Ciesielski, Manon Brien, et al.
Molecular Metabolism (2025) Vol. 92, pp. 102098-102098
Open Access
Berberine and its derivatives: mechanisms of action in myocardial vascular endothelial injury - a review
Wenhui Zhang, Shengmin Guo, Jinjin Dou, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Berberine improves cardiac insufficiency through AMPK/PGC-1α signaling-mediated mitochondrial homeostasis and apoptosis in HFpEF mice
Yingchun Hu, Xiaoyu Chen, Qiming Zhao, et al.
International Immunopharmacology (2025) Vol. 155, pp. 114613-114613
Closed Access
Modulation of GLP-1 signalling as an innovative strategy counteracting the onset of heart failure: potential for natural compound supplementation
Micaela Gliozzi, Anna Rita Coppoletta, Antonio Cardamone, et al.
Pharmacological Research (2025) Vol. 216, pp. 107744-107744
Open Access
Multi-Pharmacology of Berberine in Atherosclerosis and Metabolic Diseases: Potential Contribution of Gut Microbiota
Shengjie Yang, Dan Li, Zongliang Yu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 25
Slow digestion‐oriented dietary strategy to sustain the secretion of GLP‐1 for improved glucose homeostasis
Wangyan Qin, Ying Wang, Bruce R. Hamaker, et al.
Comprehensive Reviews in Food Science and Food Safety (2021) Vol. 20, Iss. 5, pp. 5173-5196
Closed Access | Times Cited: 25
Therapeutic application of natural compounds for skeletal muscle-associated metabolic disorders: A review on diabetes perspective
Khurshid Ahmad, Sibhghatulla Shaikh, Jeong Ho Lim, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115642-115642
Open Access | Times Cited: 10
Natural compounds as obesity pharmacotherapies
Xinyuan Zhao, Ji‐Qiu Wang, G. Gregory Neely, et al.
Phytotherapy Research (2023) Vol. 38, Iss. 2, pp. 797-838
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top